3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Inflammatory Bowel Diseases
2
Crohn Disease
2
Colitis, Ulcerative
2
Lymphoma
1
Kidney Transplantation
1
Hematologic Neoplasms
1
Granulomatous Disease, Chronic
1
Graft vs Host Disease
1
Depressive Disorder, Treatment-Resistant
1
Depressive Disorder, Major
1
Depression
1
Bronchiolitis Obliterans Syndrome
1
Bipolar Disorder
1
Interventions
Escitalopram
2
Sugars
1
Saline Solution
1
Infliximab
1
Fatty Acids, Omega-3
1
Desvenlafaxine Succinate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Depressive Disorder, Major
×
Infliximab
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts